180 Life Sciences Announces Strategic Pivot to Blockchain Following Steep Stock Decline
Biotechnology firm 180 Life Sciences has announced a complete strategic shift away from biotech towards cryptocurrency and blockchain, specifically targeting Ethereum network technology, following a significant stock market downturn. This decision comes after the company experienced a devastating stock price… Read More »180 Life Sciences Announces Strategic Pivot to Blockchain Following Steep Stock Decline